Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 4 versions Re-verified since Aug 7, 2023, no change to tracked fieldsv12-v15
  2. Primary completion date: Aug 2022 to Aug 2027
    • Study completion date: Aug 2023 to Aug 2028
    v11
  3. 2 versions Re-verified since Sep 11, 2020, no change to tracked fieldsv9-v10
  4. Primary completion date: Aug 2019 to Aug 2022
    • Study completion date: Aug 2020 to Aug 2023
    v8
  5. Primary completion date: Aug 2018 to Aug 2019v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Jan 2016 to Aug 2018
    • Study completion date: Aug 2016 to Aug 2020
    v6
  2. Primary completion date: Jan 2012 to Jan 2016v5 Show 5 more changesShow less
    • Study completion date: Jan 2012 to Aug 2016
    • Site contact updated
    • Collaborator revised
    • Eligibility criteria expanded, about 3 words
    • Study description expanded, about 2 words
  3. Site contact updatedv4
  4. Enrollment target: 500
    • Primary and study completion dates: Jan 2012
    • Start date: Jan 1988
    v3
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The metabolism of the heart provides the chemical energy needed to fuel ongoing normal heart contraction. Magnetic resonance spectroscopy is a technique used in a MRI scanner that can be used to measure and study heart metabolism directly but without blood sampling or obtaining tissue biopsies. One of the hypotheses this study aims to investigate is whether energy metabolism is reduced in heart failure and whether that contributes to the poor heart function.
Trial Details
NCT Number NCT00181259
Lead Sponsor Johns Hopkins University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Heart Failure, Congestive
Related terms Heart Failure
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov